New RSV vaccine called Arexy approved for people aged 60 and older
Health Canada has authorized the first RSV vaccine for people aged 60 and older.
Doctors have been calling for the vaccine for this group, which is at a higher risk of becoming severely ill from the virus.
Drugmaker GSK says during clinical trials, the drug was 82 percent effective at lowering respiratory tract disease caused by RSV.
In Canada, RSV season usually starts in the fall, and ends in the spring.

Province Investing Against Invasive Species
Niagara Driver Charged with Drug Impairment
Welland Man Arrested for Child Porn
28 More Doctors Hired in Niagara
Killed Police Officers Honoured by NRP
Niagara Wineries Shuttle Service Possible
Canal Days Vendors Warned of Scams
Niagara Falls Exploring Hub to Help Homeless